Appropriate dose of etoposide with cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for adult patients with acute leukemia or non-Hodgkin's lymphoma.

被引:0
|
作者
Mori, A
Tanaka, J
Hashino, S
Kahata, K
Toyoshima, N
Ota, S
Yamamoto, Y
Kobayashi, S
Asaka, M
Imamura, M
机构
[1] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hematol, Sapporo, Hokkaido, Japan
[2] Hokkaido Univ, Grad Sch Med, Dept Hematol Oncol, Sapporo, Hokkaido, Japan
[3] Hokkaido Univ, Grad Sch Med, Div Transfus Surv, Sapporo, Hokkaido, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5061
引用
收藏
页码:305B / 305B
页数:1
相关论文
共 50 条
  • [41] Rituximab salvage following relapse after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma
    Milojkovic, D
    Mijovic, A
    Taylor, CG
    Mufti, GJ
    Pagliuca, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (04) : 1013 - 1014
  • [42] Allogeneic bone marrow transplantation in patients with relapsed low-grade follicular non-Hodgkin's lymphoma (NHL).
    Mandigers, C
    Raemaekers, J
    Schattenberg, A
    Bogman, J
    Mensink, E
    deWitte, T
    BLOOD, 1995, 86 (10) : 821 - 821
  • [43] Allogeneic transplantation with PBPC is an effective option for relapsed/refractory non-Hodgkin's lymphoma.
    Tarella, C
    Caracciolo, D
    Corradini, P
    Allione, B
    Novarino, A
    Van Lint, T
    Bacigalupo, A
    Locatelli, F
    Falda, M
    BONE MARROW TRANSPLANTATION, 1999, 23 : S163 - S163
  • [44] Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV)
    Wheeler, C
    Khurshid, A
    Ibrahim, J
    Elias, A
    Mauch, P
    Ault, K
    Antin, J
    LEUKEMIA & LYMPHOMA, 2001, 40 (5-6) : 499 - 509
  • [45] Secondary acute myeloid leukemia (sAL) following treatment with etoposide-containing regimens for non-Hodgkin's lymphoma.
    Orlandi, E
    Lazzarino, M
    Bernasconi, P
    Brusamolino, E
    Pagnucco, G
    Astori, C
    Bernasconi, C
    BLOOD, 1997, 90 (10) : 348 - 348
  • [46] High dose cyclophosphamide, fractionated total body irradiation with involved field irradiation and autologous bone marrow transplantation in malignant lymphoma
    Tirona, MRBT
    Gordon, DS
    Crocker, I
    Eley, JW
    York, R
    Heffner, LT
    Winton, EF
    Vogler, WR
    LEUKEMIA & LYMPHOMA, 1996, 20 (3-4) : 249 - 257
  • [47] Autologous bone marrow transplantation following histologic transformation of indolent B cell non-Hodgkin's lymphoma.
    Friedberg, J
    Neuberg, D
    Gribben, J
    Mauch, P
    Anderson, K
    Soiffer, R
    Takvorian, T
    Fisher, D
    Schlossman, R
    Jallow, H
    Kuhlman, C
    Ritz, J
    Freedman, A
    BLOOD, 1998, 92 (10) : 727A - 727A
  • [48] Early toxicity of intensified conditioning with etoposide combined with total body irradiation cyclophosphamide or busulfan cyclophosphamide in children undergoing autologous or allogeneic bone marrow transplantation
    Horstmann, M
    Kroschke, G
    Stockschlader, M
    Betker, R
    Kruger, W
    Erttmann, R
    Kabisch, H
    Zander, A
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1996, 13 (01) : 45 - 53
  • [49] Total body irradiation, busulfan and cyclophosphamide as a conditioning regimen for allogeneic bone marrow transplantation for patients with hematological malignancies
    Kai, S
    Misawa, M
    Hara, H
    JAPANESE JOURNAL OF TRANSPLANTATION, 1999, 34 (04) : 191 - 199
  • [50] Allogeneic bone marrow transplantation in juvenile myelomonocytic leukemia without total body irradiation
    Baker, D
    Cole, C
    Price, J
    Phillips, M
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2004, 26 (03) : 200 - 203